Solace Lifesciences, Inc. — Form D

Solace Lifesciences, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-07. The offering totals $5.0M. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (13)

NameRoleLocation
Christopher G GrossDirectorWilmington, DE
Garrett G HollowayDirectorWilmington, DE
Stephen G KujawaDirectorWilmington, DE
David G PilznerDirectorWilmington, DE
James M PooleDirectorWilmington, DE
Christopher G GrossExecutive OfficerWilmington, DE
James M PooleExecutive OfficerWilmington, DE
Christopher C GrossDirectorWilmington, DE
Christopher C GrossExecutive OfficerWilmington, DE
Garrett C HollowayDirectorWilmington, DE
David C PilznerDirectorWilmington, DE
Stephen C KujawaDirectorWilmington, DE
David C AllenDirectorKerrville, TX

Other filings by this issuer (3)

FiledFormOfferingSold
2017-12-14D/A$4.0M$1.6M
2015-05-01D$4.0M—
2010-10-06D$2.0M$50K

More